Le Lézard
Classified in: Health
Subjects: PDT, FDA

First AI Enabled ROI Radiation Reduction Shutter Technology FluoroShieldtm Cleared by FDA


SANFORD, Fla., April 11, 2019 /PRNewswire/ -- Omega Medical Imaging announces the launch of FluoroShieldtm in conjunction with technology partner IKOMED Technologies, Vancouver, BC Canada. FluoroShieldtm is an Artificial Intelligence powered Region of Interest (ROI) Radiation exposure reduction solution for interventional X-ray imaging available only on Omega's Flat Panel detector CS-series product lines.

FluoroShieldtm combines the power of AI, an ultra-fast collimator and the worlds most advanced image processing to deliver a Region of Interest solution that has shown to reduce radiation exposure up to ~84 percent, seamlessly helping Interventional clinicians better reach their ALARA goals.

Omega Medical Imaging LLC based in Sanford Florida USA is an innovator in the design, manufacture, delivery, and support of Interventional X-Ray Imaging devices for hospitals and healthcare facilities around the globe.

IKOMED Technologies Inc, Vancouver, BC Canada is a medical device company developing novel medical solutions based on proprietary technology.

Details can be found at https://www.omegamedicalimaging.com.

Contact:
Megan Grosz
Omega Medical Imaging, LLC.
1-407-323-9400 X212
mgrosz@omegamedicalimaging.com 

www.omegamedicalimaging.com

Related Images

image1.png

 

SOURCE Omega Medical Imaging


These press releases may also interest you

at 21:30
Award-winning actress and producer, American Institute for Stuttering Board Member, and longtime supporter, Emily Blunt hosted the 14th annual American Institute for Stuttering's (AIS) Benefit Gala, which went virtual this year due to the Covid-19...

at 21:01
The zebrafish has been utilised as a model organism for biomedical research globally for half a century, mainly due to the high genetic similarity (over 70%) between zebrafish and human genes, with over 80% of human morbid genes related to at least...

at 20:50
Aurora Spine Corporation ("Aurora Spine" or the "Company") announces financial results for the First Quarter 2020, ended March 31, 2020.  All figures are in U.S. dollars. To our Shareholders: Q1 2020 started strongly for the Company based on...

at 19:13
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today announced the...

at 18:35
efficacyAI, Inc. announced today that it has recently signed a license agreement with the Georgia Tech Research Corporation granting it exclusive rights to the use of a suite of algorithms called MedicascyAI. This novel artificial intelligence...

at 18:32
Allergan, an AbbVie company, today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental Biologics License Application (sBLA) that supports expanded use of BOTOX® for the treatment of spasticity in pediatric patients 2...



News published on 11 april 2019 at 18:48 and distributed by: